Innovation1 Biotech Inc. filed its 10-K on Dec 15, 2022 for the period ending Aug 31, 2022. In this report its auditor, Fruci & Associates II, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0008 USD | -96.36% | -.--% | -99.07% |
17/01 | Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023 | CI |
2023 | Innovation1 Biotech Inc. announced that it has received $0.15 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-99.07% | 17.98K | |
+4.81% | 1.04B | |
-13.35% | 1.03B | |
+2.10% | 982M | |
+41.91% | 872M | |
+23.18% | 814M | |
+8.62% | 675M | |
+1.73% | 664M | |
-.--% | 600M | |
+3.61% | 503M |
- Stock Market
- Equities
- IVBT Stock
- News Innovation1 Biotech Inc.
- Innovation1 Biotech Inc. Auditor Raises 'Going Concern' Doubt